Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Frequency and type of domestic injuries among children during COVID-19 lockdown: what changes from the past? An Italian multicentre cohort study.
Bezzini D, Lanari M, Amaddeo A, Aricò MO, Castagno E, Cherchi G, Giacomini G, Graziani G, Grosso S, Liguoro I, Lombardi F, Manieri S, Moschettini L, Parisi F, Reale A, Romanisio G, Silvagni D, Schiavetti I; “Keep Me Safe” study group. Bezzini D, et al. Among authors: schiavetti i. Eur J Pediatr. 2023 Aug;182(8):3445-3454. doi: 10.1007/s00431-023-04990-6. Epub 2023 May 15. Eur J Pediatr. 2023. PMID: 37184645 Free PMC article.
Prevalence of Palliative Care Needs in Older Adults With Multimorbidity: A Multicentric Point Prevalence Study.
Tagliafico L, Maizza G, Marani C, Della Rovere F, Schiavetti I, Signori A, Petrocchi L, Ottaviani S, Muzyka M, Nencioni A, Monacelli F; Genoa's Palliative Care Day Network. Tagliafico L, et al. Among authors: schiavetti i. J Am Med Dir Assoc. 2023 Sep;24(9):1278-1281. doi: 10.1016/j.jamda.2023.05.015. Epub 2023 Jun 20. J Am Med Dir Assoc. 2023. PMID: 37353204 No abstract available.
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
Sormani MP, De Rossi N, Schiavetti I, Carmisciano L, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, Trojano M, Zaratin P, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M; Musc-19 Study Group. Sormani MP, et al. Among authors: schiavetti i. Ann Neurol. 2021 Apr;89(4):780-789. doi: 10.1002/ana.26028. Epub 2021 Feb 9. Ann Neurol. 2021. PMID: 33480077 Free PMC article.
CD19+ B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis.
Schiavetti I, Barcellini L, Lapucci C, Tazza F, Cellerino M, Capello E, Franciotta D, Inglese M, Sormani MP, Uccelli A, Laroni A. Schiavetti I, et al. Mult Scler Relat Disord. 2023 Feb;70:104494. doi: 10.1016/j.msard.2022.104494. Epub 2022 Dec 30. Mult Scler Relat Disord. 2023. PMID: 36603292 Free PMC article.
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab.
Signoriello E, Signori A, Lus G, Romano G, Marfia GA, Landi D, Napoli F, D' Amico E, Zanghí A, Di Filippo PS, Caliendo D, Carotenuto A, Spiezia AL, Fantozzi R, Centonze D, Lucchini M, Mirabella M, Cocco E, Frau J, Maniscalco GT, Di Battista ME, Foschi M, Surcinelli A, Bonavita S, Abbadessa G, Pasquali L, Di Gregorio M, Ferrò MT, Sormani MP, Schiavetti I; ON focus study group. Signoriello E, et al. Among authors: schiavetti i. Mult Scler Relat Disord. 2024 Apr 6;87:105594. doi: 10.1016/j.msard.2024.105594. Online ahead of print. Mult Scler Relat Disord. 2024. PMID: 38718748 Free article.
Therapeutic lag: Is treatment effect delayed in progressive MS?
Montobbio N, Bovis F, Signori A, Ponzano M, Schiavetti I, Sormani MP. Montobbio N, et al. Among authors: schiavetti i. Mult Scler. 2024 Apr 14:13524585241244751. doi: 10.1177/13524585241244751. Online ahead of print. Mult Scler. 2024. PMID: 38616520
116 results